Latest Headlines

31. Guardant Health's Shield Blood-Based Screening Test For Colorectal Cancer Now Accessible Through National Test Ordering And Collection Network Of Quest Diagnostics 3/10/2026

    Guardant Health, Inc. a leading precision oncology company, today announced that the Shield by Guardant blood-based screening test is now widely accessible for physician order through the nationwide connectivity of Quest Diagnostics, equipping clinicians with access to blood-based screening innovation for colorectal cancer (CRC) through one of the largest diagnostic ecosystems in the United States.

32. Clarapath Launches Its Latest SectionStar™ Platform For Clinical Histology Workflows 3/10/2026

    Clarapath, a leader in automated tissue sectioning solutions for anatomic pathology, recently announced the latest release of SectionStar™, the next-generation version of its robotic microtomy platform.

33. Waters Flagship ARES G3 Rheometer Sets New Benchmark For Data Quality At Breakthrough Speed 3/9/2026

    Pittcon 2026 Conference + Exposition -- Waters Corporation (NYSE: WAT) today launched the ARES-G3™ Rheometer, part of the TA Instruments product line.

34. Beckman Coulter Diagnostics Selects Innovaccer Gravity As AI And Data Platform For Clinical Laboratory Operations Modernization 3/9/2026

    Innovaccer Inc., a leading healthcare AI company, today announced that Beckman Coulter Diagnostics, a global clinical diagnostics leader and a Danaher company, has selected Gravity, Innovaccer’s enterprise data and AI platform, to support its vision for modernizing and scaling customers’ clinical laboratory operations.

35. LabVantage Solutions Introduces LabVantage CORTEX, Advancing Its LIMS Platform For AI-Driven Laboratory Operations 3/5/2026

    LabVantage Solutions, Inc., a global provider of laboratory informatics solutions and services, today announced the launch of LabVantage CORTEX, a next-generation artificial intelligence (AI), analytics, and automation platform.

36. Frontage Laboratories Completes Acquisition Of Teddy Lab, Strengthening Global Central Laboratory Capabilities 3/4/2026

    rontage Laboratories, Inc. ("Frontage"), a leading global CRO/CDMO, today announced the completion of the acquisition of Teddy Clinical Research Laboratory (Shanghai), Ltd. ("Teddy Lab"), a leading clinical research laboratory service provider in China.

37. US BioTek Laboratories Completes Merger With NutriPATH Pathology 3/3/2026

    US BioTek Laboratories, a leading functional laboratory specializing in advanced immunological and integrative diagnostics, today announced the completion of its merger with NutriPATH Pathology, a respected functional pathology laboratory serving integrative and functional medicine practitioners.

38. Pillar Biosciences Launches oncoReveal® Rapid AML Panel To Support Rapid, Guideline Informed Genomic Insights For Acute Myeloid Leukemia 3/3/2026

    Pillar Biosciences today announced the launch of the oncoReveal® Rapid AML Panel, a focused research-use-only (RUO) DNA next-generation sequencing (NGS) panel designed to help laboratories generate key acute myeloid leukemia (AML) genomic results more efficiently.

39. PathAI Receives U.S. FDA Breakthrough Device Designation For PathAssist Derm, An AI-Powered Pathology Solution To Transform Dermatopathology Workflow 3/3/2026

    PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to PathAssist Derm¹, designed to analyze digital pathology whole slide images (WSIs) of skin lesions and aid pathologists in their review.

40. Lucent Diagnostics And Life Line Screening Partner To Bring Advanced Blood-Based Diagnostics To Communities Nationwide 3/2/2026

    Lucent Diagnostics, a brand of Quanterix Corporation today announced a partnership with Life Line Screening (LLS), a national organization focused on identifying asymptomatic risks for chronic conditions in community health settings.